These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1716798

  • 1. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection.
    Dalmasso AP, Vercellotti GM, Platt JL, Bach FH.
    Transplantation; 1991 Sep; 52(3):530-3. PubMed ID: 1716798
    [Abstract] [Full Text] [Related]

  • 2. Reaction of complement with endothelial cells in a model of xenotransplantation.
    Dalmasso AP, Platt JL, Bach FH.
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
    [Abstract] [Full Text] [Related]

  • 3. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP, Platt JL.
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [Abstract] [Full Text] [Related]

  • 4. A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation.
    Kroshus TJ, Salerno CT, Yeh CG, Higgins PJ, Bolman RM, Dalmasso AP.
    Transplantation; 2000 Jun 15; 69(11):2282-9. PubMed ID: 10868627
    [Abstract] [Full Text] [Related]

  • 5. Presence of human chromosome 1 with expression of human decay-accelerating factor (DAF) prevents lysis of mouse/human hybrid cells by human complement.
    Wang MW, Wright LJ, Sims MJ, White DJ.
    Scand J Immunol; 1991 Dec 15; 34(6):771-8. PubMed ID: 1721235
    [Abstract] [Full Text] [Related]

  • 6. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
    Zhao Z, Termignon JL, Cardoso J, Chéreau C, Gautreau C, Calmus Y, Houssin D, Weill B.
    Transplantation; 1994 Jan 15; 57(2):245-9. PubMed ID: 8310516
    [Abstract] [Full Text] [Related]

  • 7. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S, Mikata S, Shirakura R, Matsuda H, Nagasawa S, Terados A, Hatanaka M, Matsumoto M, Seya T.
    Scand J Immunol; 1996 Apr 15; 43(4):361-6. PubMed ID: 8668913
    [Abstract] [Full Text] [Related]

  • 8. Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection.
    Thomas H, Maillet F, Letourneur D, Jozefonvicz J, Fischer E, Kazatchkine MD.
    Mol Immunol; 1996 Apr 15; 33(7-8):643-8. PubMed ID: 8760276
    [Abstract] [Full Text] [Related]

  • 9. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.
    Charreau B, Ménoret S, Tesson L, Azimzadeh A, Audet M, Wolf P, Marquet R, Verbakel C, Ijzermans J, Cowan P, Pearse M, d'Apice A, Soulillou JP, Anegon I.
    Mol Med; 1999 Sep 15; 5(9):617-30. PubMed ID: 10551903
    [Abstract] [Full Text] [Related]

  • 10. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells.
    Boulday G, Hamann J, Soulillou JP, Charreau B.
    Transplantation; 2002 Feb 15; 73(3):429-36. PubMed ID: 11884941
    [Abstract] [Full Text] [Related]

  • 11. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
    Schmoeckel M, Nollert G, Shahmohammadi M, Young VK, Chavez G, Kasper-König W, White DJ, Müller-Höcker J, Arendt RM, Wilbert-Lampen U, Hammer C, Reichart B.
    Transplantation; 1996 Sep 27; 62(6):729-34. PubMed ID: 8824468
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of double transfection to xenoendothelial cells using both decay accelerating factor and homologous restriction factor 20 genes on complement dependent cytolysis.
    Hayashi S, Emi N, Isobe K, Yokoyama I, Okada H, Takagi H.
    J Surg Res; 1996 Feb 15; 61(1):165-9. PubMed ID: 8769961
    [Abstract] [Full Text] [Related]

  • 13. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ, Salvaris E, Romanella M, Aminian A, Katerelos M, Tange MJ, Pearse MJ, d'Apice AJ.
    Transplantation; 1997 Sep 27; 64(6):882-8. PubMed ID: 9326415
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
    Hayashi S, Isobe K, Emi N, Yokoyama I, Okada H, Nakashima I, Takagi H.
    Eur Surg Res; 1996 Sep 27; 28(6):440-6. PubMed ID: 8954321
    [Abstract] [Full Text] [Related]

  • 15. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.
    Miyagawa S, Shirakura R, Iwata K, Nakata S, Matsumiya G, Izutani H, Matsuda H, Terado A, Matsumoto M, Nagasawa S.
    Transplantation; 1994 Oct 15; 58(7):834-40. PubMed ID: 7524206
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M, Shiraishi M, Oshiro T, Taira K, Sugawa H, Nozato E, Nomura H, Nagamine M, Muto Y.
    Transpl Int; 2002 May 15; 15(5):205-11. PubMed ID: 12012040
    [Abstract] [Full Text] [Related]

  • 17. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
    Begum NA, Murakami Y, Mikata S, Matsumoto M, Hatanaka M, Nagasawa S, Kinoshita T, Seya T.
    Immunology; 2000 May 15; 100(1):131-9. PubMed ID: 10809968
    [Abstract] [Full Text] [Related]

  • 18. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
    Laumonier T, Walpen AJ, Maurus CF, Mohacsi PJ, Matozan KM, Korchagina EY, Bovin NV, Vanhove B, Seebach JD, Rieben R.
    Transplantation; 2003 Sep 15; 76(5):838-43. PubMed ID: 14501864
    [Abstract] [Full Text] [Related]

  • 19. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
    Lam TT, Hausen B, Hook L, Lau M, Higgins J, Christians U, Jacobsen W, Baluom M, Duthaler R, Katopodis A, Chavez G, Cozzi E, Harrison R, Schuurman HJ, Borie D, Morris RE.
    Xenotransplantation; 2005 Jan 15; 12(1):20-9. PubMed ID: 15598270
    [Abstract] [Full Text] [Related]

  • 20. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S, Kubo T, Matsunami K, Kusama T, Beppu K, Nozaki H, Moritan T, Ahn C, Kim JY, Fukuta D, Shirakura R.
    J Immunol; 2004 Sep 15; 173(6):3945-52. PubMed ID: 15356143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.